SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lactose (India) informs about outcome of board meeting

19 Mar 2022 Evaluate

In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lactose (India) has informed the Stock Exchange that the Board of Directors of the Company at their meeting held on Saturday, 19th March, 2022 has, considered the Appointment of Dhaval Jayant Soni as an Independent Director of the company with effect from 19th March, 2022 for a period of 5 years. The meeting commenced at 02.00 pm and concluded at 03:00 pm.

The above information is a part of company’s filings submitted to BSE.

Lactose India Share Price

97.88 9.00 (10.13%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×